Younossi Z - Search Results

1

Complexity of ballooned hepatocyte feature recognition: Defining a training atlas for artificial intelligence-based imaging in NAFLD.

Brunt EM, Clouston AD, Goodman Z, Guy C, Kleiner DE, Lackner C, Tiniakos DG, Wee A, Yeh M, Leow WQ, Chng E, Ren Y, Boon Bee GG, Powell EE, Rinella M, Sanyal AJ, Neuschwander-Tetri B, Younossi Z, Charlton M, Ratziu V, Harrison SA, Tai D, Anstee QM. Brunt EM, et al. Among authors: younossi z. J Hepatol. 2022 May;76(5):1030-1041. doi: 10.1016/j.jhep.2022.01.011. Epub 2022 Jan 25. J Hepatol. 2022. PMID: 35090960 Free PMC article.

2

Nonalcoholic fatty liver disease: an agenda for clinical research.

Younossi ZM, Diehl AM, Ong JP. Younossi ZM, et al. Hepatology. 2002 Apr;35(4):746-52. doi: 10.1053/jhep.2002.32483. Hepatology. 2002. PMID: 11915019 Review. No abstract available.

3

Non-alcoholic fatty liver disease: an overview.

Mulhall BP, Ong JP, Younossi ZM. Mulhall BP, et al. J Gastroenterol Hepatol. 2002 Nov;17(11):1136-43. doi: 10.1046/j.1440-1746.2002.02881.x. J Gastroenterol Hepatol. 2002. PMID: 12453271 Review.

4

Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C.

Poynard T, Ratziu V, McHutchison J, Manns M, Goodman Z, Zeuzem S, Younossi Z, Albrecht J. Poynard T, et al. Among authors: younossi z. Hepatology. 2003 Jul;38(1):75-85. doi: 10.1053/jhep.2003.50267. Hepatology. 2003. PMID: 12829989 Clinical Trial.

5

Pathologic features associated with fibrosis in nonalcoholic fatty liver disease.

Gramlich T, Kleiner DE, McCullough AJ, Matteoni CA, Boparai N, Younossi ZM. Gramlich T, et al. Hum Pathol. 2004 Feb;35(2):196-9. doi: 10.1016/j.humpath.2003.09.018. Hum Pathol. 2004. PMID: 14991537

6

Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients.

Ong JP, Elariny H, Collantes R, Younoszai A, Chandhoke V, Reines HD, Goodman Z, Younossi ZM. Ong JP, et al. Among authors: younossi zm. Obes Surg. 2005 Mar;15(3):310-5. doi: 10.1381/0960892053576820. Obes Surg. 2005. PMID: 15826462

7

Hepatic gene expression in patients with obesity-related non-alcoholic steatohepatitis.

Younossi ZM, Gorreta F, Ong JP, Schlauch K, Del Giacco L, Elariny H, Van Meter A, Younoszai A, Goodman Z, Baranova A, Christensen A, Grant G, Chandhoke V. Younossi ZM, et al. Liver Int. 2005 Aug;25(4):760-71. doi: 10.1111/j.1478-3231.2005.01117.x. Liver Int. 2005. PMID: 15998427

8

A genomic and proteomic study of the spectrum of nonalcoholic fatty liver disease.

Younossi ZM, Baranova A, Ziegler K, Del Giacco L, Schlauch K, Born TL, Elariny H, Gorreta F, VanMeter A, Younoszai A, Ong JP, Goodman Z, Chandhoke V. Younossi ZM, et al. Hepatology. 2005 Sep;42(3):665-74. doi: 10.1002/hep.20838. Hepatology. 2005. PMID: 16116632

9

Gene expression of leptin, resistin, and adiponectin in the white adipose tissue of obese patients with non-alcoholic fatty liver disease and insulin resistance.

Baranova A, Gowder SJ, Schlauch K, Elariny H, Collantes R, Afendy A, Ong JP, Goodman Z, Chandhoke V, Younossi ZM. Baranova A, et al. Among authors: younossi zm. Obes Surg. 2006 Sep;16(9):1118-25. doi: 10.1381/096089206778392149. Obes Surg. 2006. PMID: 16989692

10

Pathologic assessment of non-alcoholic fatty liver disease.

Bondini S, Kleiner DE, Goodman ZD, Gramlich T, Younossi ZM. Bondini S, et al. Clin Liver Dis. 2007 Feb;11(1):17-23, vii. doi: 10.1016/j.cld.2007.02.002. Clin Liver Dis. 2007. PMID: 17544969 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

736 results

Search Page